Yong‐Sheng Xiao

机构：Ministry of Education of the People's Republic of China, University of Nottingham Ningbo China, Sun Yat-sen University, Chengdu Medical College, Tencent (China), Lanzhou University of Technology, Fudan University, Ministry of Education, Shanghai Institute of Organic Chemistry, Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University, Ministry of Education

发表论文 78 篇 · 总被引 4493 次 · h-index 24

代表论文

• CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma (2024 · Journal of Hepatology · 被引 65)
• Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study (2025 · The Lancet Oncology · 被引 20)
• CYP1B1 promotes colorectal cancer liver metastasis by enhancing the growth of metastatic cancer cells via a fatty acids-dependent manner (2023 · Journal of Gastrointestinal Oncology · 被引 13)
• Galectin-4 drives anti-PD-L1/BVZ resistance by regulating metabolic adaptation and tumour-associated neutrophils in hepatocellular carcinoma (2025 · Gut · 被引 10)
• SIGLEC15, negatively correlated with PD-L1 in HCC, could induce CD8+ T cell apoptosis to promote immune evasion (2024 · OncoImmunology · 被引 7)
• GOLM1 dictates acquired Lenvatinib resistance by a GOLM1-CSN5 positive feedback loop upon EGFR signaling activation in hepatocellular carcinoma (2024 · Oncogene · 被引 5)